South Africa / Aspen Inks Deal to Manufacture J&J’s COVID-19 Vaccine
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed…
Teva Pharmaceuticals(SA 2011)
Last updated: 13.02.2014
Address: Suite 2 Building 4 Ruimsig Office Estate, Hole in One Avenue, Ruimsig, 1724 Roodepoort, Gauteng, South Africa
Tel: +27-11-9582168
Web: http://www.tevapharm.com/Pages/default.aspx
Company description
Established in 1901, Teva takes great pride in its long tradition of leadership and dedication to excellence.
Teva is a global generic pharmaceuticals leader and one of the top 15 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 47,000 employees worldwide.
Established in 1901, Teva takes great pride in its long tradition of leadership and dedication to excellence.
Teva specializes in development, production and marketing of a wide range of generic and branded products, as well as active pharmaceutical ingredients (API).
For over a century, Teva has maintained a distinct competitive edge through:
High quality offerings
Focus on customers and patients
Balanced product portfolio (both generic and innovative)
Integration of pharmaceutical and API activities
Combination of global operations with local customer responsiveness
Established international presence through a tailored network of worldwide subsidiaries
Products and services
Teva aims to be the first to introduce the highest quality standards and the most competitive prices.
Teva’s branded products make a significant difference in people’s lives. We leverage our large-scale operations, scientific resources and global leadership to develop and produce drugs that are tailored to address patients’ needs.
Only the highest quality standards are implemented to ensure our customers’ wellbeing. As our branded business expands, we continue to explore new areas and exciting platforms, in pursuit of new products that can enhance your quality of life.
Related
Opinion / Malaria Prevention Cannot be Allowed to Stall During the COVID-19 Pandemic
As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr…
COVID-19 / Cipla to Begin Manufacturing Remdesivir in South Africa
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a…
News Roundup / South Africa Pharma June 2020
Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a…
Rare Diseases in South Africa: Bridging the Gap for Inclusive Healthcare
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when…
Medical Device Segment braced for change in South Africa
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device…
Tackling South Africa’s “Intimate Healthcare” Needs
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it…
South African Clinical Trials: Turning Diversity into Opportunity
Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease…
Showcasing South African innovation
While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem…
Interview: Andre Buhrlen – Managing Director, Hersol Manufacturing…
Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract…
Interview: Albert Denoon – Owner, Baroque Medical, – Board Member,…
Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit…
Interview: Charl De Klerk – General Manager, Bard South Africa
The general manager of Bard SA, Charl De Klerk, illustrates the company’s growth ambitions within South Africa…
